Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo

Gopal Thinakaran, David R. Borchelt, Michael K. Lee, Hilda H. Slunt, Lia Spitzer, Grace Kim, Tamara Ratovitsky, Frances Davenport, Christer Nordstedt, Mary Seeger, John Hardy, Allan I. Levey, Samuel E. Gandy, Nancy A. Jenkins, Neal G. Copeland, Donald L. Price, Sangram S. Sisodia

Research output: Contribution to journalArticle

912 Scopus citations

Abstract

The majority of early-onset cases of familial Alzheimer's disease (FAD) are linked to mutations in two related genes, PS1 and PS2, located on chromosome 14 and 1, respectively. Using two highly specific antibodies against nonoverlapping epitopes of the PS1-encoded polypeptide, termed presenilin 1 (PS1), we document that the preponderant PS1-related species that accumulate in cultured mammalian cells, and in the brains of rodents, primates, and humans are ~27-28 kDa N-terminal and ~16-17 kDa C-terminal derivatives. Notably, a FAD-linked PS1 variant that lacks exon 9 is not subject to endoproteolytic cleavage. In brains of transgenic mice expressing human PS1, ~17 kDa and ~27 kDa PS1 derivatives accumulate to saturable levels, and at ~1:1 stoichiometry, independent of transgene-derived mRNA. We conclude that PS1 is subject to endoproteolytic processing in vivo.

Original languageEnglish (US)
Pages (from-to)181-190
Number of pages10
JournalNeuron
Volume17
Issue number1
DOIs
StatePublished - Jul 1996

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo'. Together they form a unique fingerprint.

Cite this